Upregulation of expression of the mentioned genes is accompanied by an increase in the transcription of genes, such as atrogin-1 (also known as muscle atrophy F-box, MAFbx), involved in proteasomal- and lysosomal-mediated protein degradation and thus in skeletal muscle atrophy [6,7]. The gene discussed is FBXO32; the disease is muscle atrophy.